Department of Psychiatry, Elgin Early Intervention Program for Psychosis, University of Western Ontario, London, Ontario, Canada ; Mental Health Resource Foundation, Mumbai, Maharashtra, India.
Department of Psychology, University of Toronto, St. George, Toronto, Canada.
Indian J Psychiatry. 2014 Jan;56(1):8-16. doi: 10.4103/0019-5545.124708.
Cannabis is a known risk factor for schizophrenia, although the exact neurobiological process through which the effects on psychosis occur is not well-understood. In this review, we attempt to develop and discuss a possible pathway for the development of psychosis. We examine the neurobiological changes due to cannabis to see if these changes are similar to those seen in schizophrenic patients the findings show similarities; however, these mere similarities cannot establish a 'cause-effect' relationship as a number of people with similar changes do not develop schizophrenia. Therefore, the 'transition-to-psychosis' due to cannabis, despite being a strong risk factor, remains uncertain based upon neurobiological changes. It appears that other multiple factors might be involved in these processes which are beyond neurobiological factors. Major advances have been made in understanding the underpinning of marijuana dependence, and the role of the cannabinoid system, which is a major area for targeting medications to treat marijuana withdrawal and dependence, as well as other addictions is of now, it is clear that some of the similarities in the neurobiology of cannabis and schizophrenia may indicate a mechanism for the development of psychosis, but its trajectories are undetermined.
大麻是精神分裂症的已知风险因素,尽管其导致精神病发作的确切神经生物学过程尚未得到很好的理解。在这篇综述中,我们试图提出并讨论精神分裂症发展的可能途径。我们检查了大麻引起的神经生物学变化,以观察这些变化是否与精神分裂症患者的变化相似;然而,这些相似之处并不能确立“因果关系”,因为许多有类似变化的人并没有发展为精神分裂症。因此,尽管大麻是一个很强的风险因素,但由于神经生物学变化,“向精神病的转变”仍然不确定。似乎还有其他多种因素可能参与了这些过程,而这些因素超出了神经生物学因素的范围。在理解大麻依赖的基础以及大麻素系统的作用方面已经取得了重大进展,大麻素系统是针对药物治疗大麻戒断和依赖以及其他成瘾的主要靶点,目前,大麻和精神分裂症的神经生物学相似性可能表明精神分裂症发展的机制,但它的轨迹尚未确定。